Results overview: Found 1 records in 0.03 seconds.
Articles, 1 records found
Articles 1 records found  
1.
18 p, 948.8 KB Economic Impact of Etanercept in Patients with Psoriasis and Psoriatic Arthritis in Spain : A Systematic Review / Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Fernández-Freire, Lourdes Rodríguez (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Burgos-Pol, Ramón (Pharmacoeconomics and Outcomes Research Iberia (PORIB)) ; Gomez, Ismael (Pfizer S.L.U.) ; Peral, Carmen (Pfizer S.L.U.) ; Gomez, Susana (Pfizer S.L.U.) ; Rebollo Laserna, Francisco José (Pfizer S.L.U.) ; Universitat Autònoma de Barcelona
Etanercept (ETN), a highly effective biological agent for the treatment of psoriasis (PSO) and psoriatic arthritis (PsA), is widely used in Spain. However, evidence of its economic impact is limited, indicating the need for a systematic review of the economic assessments conducted on the use of ETN in the treatment of both PSO and PsA in Spain. [...]
2019 - 10.1007/s13555-019-0301-6
Dermatology and Therapy, Vol. 9 Núm. 3 (january 2019) , p. 479-496  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.